Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Live Webinar: Poker face revealed: Using facial analysis to reveal deeper emotional insights

February 4, 2019 | Facial analysis, Pharma, digital health, healthcare, webinar 

Thursday 28th February 2019, 10:00 EST / 15:00 GMT / 16:00 CET

Thursday 28th February 2019
10:00 EST / 15:00 GMT / 16:00 CET
Register now to secure your place » 

Does your expression give you away? According to psychologists, a lot of emotional information can be drawn from our facial expressions. Brief, involuntary flashes of emotion or ‘micro-expressions’ can reveal a lot about a person’s true feelings. As market researchers interested in the emotional responses driving people’s attitudes and behaviours, this information is invaluable but can often be difficult to obtain. One of the latest innovations in market research is facial analysis, which uses recognition software to detect a range of emotions in faces.

Register now to secure your place » 

Join us for this complimentary webinar event hosted in partnership with emotion measurement company, Affectiva, which has analysed over 5,000,000 faces and 24,000 adverts to understand how people respond to digital stimulus such as advertisements, websites and smartphone apps. We will demonstrate how, over the past several years, we’ve been using facial analysis in both qualitative and quantitative settings to delve further into respondents’ reactions to healthcare communications.

What are the key takeaways?

The theory
Learn more about the science and technology underpinning facial and emotional analysis.

Applications in healthcare MRX
Discover how we used facial analysis to deliver additional insights in a pharmaceutical setting.

Key considerations
Find out about the logistical challenges of using this methodology and how to overcome them.

Looking forwards
Explore future applications of facial analysis including integration with other technologies.

Gain answers to your key questions
At the end of the webinar there will be a live Q&A session. Start the conversation by submitting your questions in advance when you register.

Thursday 28th February 2019
10:00 EST / 15:00 GMT / 16:00 CET
Register now to secure your place »

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

What oncologists really want from booth strategy

Simon Davenport, Global Head of Environments, Emota, an Inizio Engage company  At this year’s ASCO® congress, the spotlight wasn’t just on science – it was on how the industry engages. Supporting over 30...

How smart spaces and real-time strategy transformed ASCO® 2025

Nick Bellomo, Director of Technology and Engagement, Inizio Medical ASCO® 2025 wasn’t just about oncology breakthroughs - it was also a showcase for how technology is redefining congress engagement. Supporting...

The science is shifting in oncology: Are you ready to evolve with it?

Patty Zipfel, PhD, SVP, Scientific Strategy, Inizio Evoke. This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial design in metastatic...

Reimagine health with Inizio.

At Inizio, we provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Our experts guide you through each...

Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...

Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot

This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

Authored by: Ellie Forde and Mark Braund, Directors

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...